Ugh, this is a difficult one. Pfizer’s stock is at $25.88, up a little 0.5%. Sales in China are slipping, and legal issues are still hanging over the company, which is never a good thing. Some people see this as a buying chance, but I think it’s risky. I guess I'll wait for new product launches and court stuff to see what’s next.
There are no replies in this thread yet. Be the first to post a reply below: